Epidemiology and risk factors for chronic kidney disease.

[1]  L. Bostad,et al.  The relationship between atherosclerosis of the thoracic aorta and renal scarring in an autopsy material. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[2]  W. McClellan,et al.  Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[3]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[4]  R. Harrist,et al.  Cigarette Smoking Exacerbates and Its Cessation Ameliorates Renal Injury in Type 2 Diabetes , 2004, The American journal of the medical sciences.

[5]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[6]  S. Cochran,et al.  Classification of race and ethnicity: implications for public health. , 2003, Annual review of public health.

[7]  D. Sandler,et al.  Lifestyle risk factors and chronic kidney disease. , 2003, Annals of epidemiology.

[8]  Josef Coresh,et al.  Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. , 2003, Journal of the American Society of Nephrology : JASN.

[9]  E. Vittinghoff,et al.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. , 2003, Journal of the American Society of Nephrology : JASN.

[10]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[11]  F. Dekker,et al.  Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  C. Lewis,et al.  Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study. , 2003, Journal of the American Society of Nephrology : JASN.

[13]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[14]  N. Powe,et al.  Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Neil R. Powe,et al.  Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.

[16]  K. Iseki,et al.  Blood Pressure Predicts Risk of Developing End‐Stage Renal Disease in Men and Women , 2003, Hypertension.

[17]  G. Eknoyan.  Meeting the challenges of the new K/DOQI guidelines. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[19]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[20]  J. Vandenbroucke,et al.  Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy , 2003, Diabetologia.

[21]  J. Cooper,et al.  Renal function and risk stratification in acute coronary syndromes. , 2003, The American journal of cardiology.

[22]  W. S. St. Peter,et al.  Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  D. Spiegelman,et al.  The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency , 2003, Annals of Internal Medicine.

[24]  Rosario V. Freeman,et al.  Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. , 2003, Journal of the American College of Cardiology.

[25]  N. Weissman,et al.  Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention. , 2003, American heart journal.

[26]  M. Carnethon,et al.  Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  K. Sud,et al.  End-stage renal disease in India and Pakistan: burden of disease and management issues. , 2003, Kidney international. Supplement.

[28]  G. Breithardt,et al.  Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. , 2003, Kidney international.

[29]  F. Sacks,et al.  Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency , 2003, Annals of Internal Medicine.

[30]  A. Algra,et al.  Influence of atherosclerosis on age‐related changes in renal size and function , 2003, European journal of clinical investigation.

[31]  C. Jurkovitz,et al.  Family members of patients treated for ESRD have high rates of undetected kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  C. Camargo,et al.  Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. , 2002, American heart journal.

[33]  R. Prescott,et al.  Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. , 2002, Journal of the American College of Cardiology.

[34]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[35]  P. Kimmel,et al.  New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. , 2002, Seminars in nephrology.

[36]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[37]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[38]  M. Lauer,et al.  The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. , 2002, Journal of the American College of Cardiology.

[39]  B. Psaty,et al.  Cardiovascular disease risk status in elderly persons with renal insufficiency. , 2002, Kidney international.

[40]  N. Powe,et al.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. , 2002, Journal of the American Society of Nephrology : JASN.

[41]  R. Barsoum.  Overview: end-stage renal disease in the developing world. , 2002, Artificial organs.

[42]  R. Califf,et al.  Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.

[43]  G. Santoro-Lopes,et al.  Familial Aggregation of End-Stage Kidney Disease in Brazil , 2002, Nephron.

[44]  F. Port,et al.  Risk factors for proteinuria in a large, multiracial, southeast Asian population. , 2002, Journal of the American Society of Nephrology : JASN.

[45]  V. Kher.  End-stage renal disease in developing countries. , 2002, Kidney international.

[46]  S. Reis,et al.  Mild Renal Insufficiency Is Associated With Angiographic Coronary Artery Disease in Women , 2002, Circulation.

[47]  A. Garg,et al.  Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III , 2002 .

[48]  B. Kiberd,et al.  Cumulative risk for developing end-stage renal disease in the US population. , 2002, Journal of the American Society of Nephrology : JASN.

[49]  S. Snapinn,et al.  Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial , 2002, Circulation.

[50]  M. Mitsnefes,et al.  Body mass index and allograft function in pediatric renal transplantation , 2002, Pediatric Nephrology.

[51]  R. Califf,et al.  Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation , 2002, Circulation.

[52]  A. Garg,et al.  Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). , 2002, Journal of the American Society of Nephrology : JASN.

[53]  G. Kimura,et al.  Regional variation in end-stage renal disease , 2002, Current opinion in nephrology and hypertension.

[54]  Lundy Braun.  Race, Ethnicity, and Health: Can Genetics Explain Disparities? , 2002, Perspectives in biology and medicine.

[55]  R. Fischer,et al.  Stopping smoking slows accelerated progression of renal failure in primary renal disease. , 2002, Journal of nephrology.

[56]  M. Bell,et al.  The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. , 2002, Journal of the American College of Cardiology.

[57]  A. Collins,et al.  United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[60]  D. Butkus.  Familial clustering of end-stage renal disease in Mississippi. , 2002, Journal of the Mississippi State Medical Association.

[61]  F. Dekker,et al.  When to initiate dialysis: effect of proposed US guidelines on survival , 2001, The Lancet.

[62]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[63]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[64]  G. Eknoyan,et al.  The national epidemic of chronic kidney disease , 2001, Postgraduate medicine.

[65]  M. Cosma,et al.  Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[66]  R. Califf,et al.  Differential survival after coronary revascularization procedures among patients with renal insufficiency. , 2001, Kidney international.

[67]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[68]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[69]  N. Chaturvedi.  Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. , 2001, Annals of internal medicine.

[70]  D. Simmons,et al.  Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[71]  I. Palacios,et al.  Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era? , 2000, Circulation.

[72]  M. Laville,et al.  Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  G. Bakris,et al.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  B. Giraudeau,et al.  Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. , 2000, Kidney international.

[75]  J. Yee,et al.  Risks associated with renal dysfunction in patients in the coronary care unit. , 2000, Journal of the American College of Cardiology.

[76]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[77]  A. Collins.  End-stage renal disease , 2000, Postgraduate medicine.

[78]  L. Huiart,et al.  Timing of nephrology referral: influence on mortality and morbidity. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  A. Kshirsagar,et al.  Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[80]  W. van Biesen,et al.  The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[81]  A. Kausz,et al.  Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. , 1999, Journal of the American Society of Nephrology : JASN.

[82]  L. Baker,et al.  Temporary vascular access for first dialysis is common, undesirable and usually avoidable. , 1999, Clinical nephrology.

[83]  E. Friedman,et al.  Delayed referral of black, Hispanic, and older patients with chronic renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[84]  J. Gross,et al.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.

[85]  P. Padfield,et al.  Diabetic nephropathy is associated with an increased familial risk of stroke. , 1999, Diabetes care.

[86]  Ambady Ramachandran,et al.  Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India. , 1999, Diabetes research and clinical practice.

[87]  Thomas E. Moritz,et al.  Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery , 1999 .

[88]  E. Feuer,et al.  Comparison of risk estimates for selected diseases and causes of death. , 1999, Preventive medicine.

[89]  F. Valderrábano,et al.  Hypertension as cause of end-stage renal disease: lessons from international registries. , 1998, Kidney international. Supplement.

[90]  J. Coresh,et al.  Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[91]  P. Ellis,et al.  Late referral of end-stage renal failure. , 1998, QJM : monthly journal of the Association of Physicians.

[92]  P. Parfrey,et al.  Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[94]  M. Fullilove,et al.  Comment: abandoning "race" as a variable in public health research--an idea whose time has come. , 1998, American journal of public health.

[95]  J. Gross,et al.  Increased Familial History of Arterial Hypertension, Coronary Heart Disease, and Renal Disease in Brazilian Type 2 Diabetic Patients With Diabetic Nephropathy , 1998, Diabetes Care.

[96]  C. Wanner,et al.  Smoking as a risk factor for end-stage renal failure in men with primary renal disease. , 1998, Kidney international.

[97]  J. Domico,et al.  Early referral and its impact on emergent first dialyses, health care costs, and outcome. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[98]  P. Whelton,et al.  Familial aggregation of renal disease in a population-based case-control study. , 1998, Journal of the American Society of Nephrology : JASN.

[99]  T A Louis,et al.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[100]  G. Remuzzi,et al.  Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). , 1998, Kidney international.

[101]  P. Whelton,et al.  Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. , 1997, JAMA.

[102]  P. Whelton,et al.  Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT , 1997 .

[103]  B. Brenner,et al.  Nephron mass as a risk factor for progression of renal disease. , 1997, Kidney international. Supplement.

[104]  B. Freedman,et al.  Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.

[105]  G. Eknoyan,et al.  National Kidney Foundation: Dialysis Outcome Quality Initiative--development of methodology for clinical practice guidelines. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[106]  O. B. O. T. I. Group,et al.  Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM , 1997, Diabetologia.

[107]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[108]  O. Tomonaga,et al.  Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients , 1997, Diabetologia.

[109]  G. Bakris,et al.  Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. , 1997, Hypertension.

[110]  S. Leurgans,et al.  Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.

[111]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[112]  Ping Wang,et al.  The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.

[113]  D. Warnock,et al.  Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[114]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[115]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[116]  F. Nuttall,et al.  Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial , 1995, Diabetes Care.

[117]  P. Whelton,et al.  Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. , 1995, Archives of internal medicine.

[118]  H. Lebovitz,et al.  Interaction of hypertension and diabetes on renal function in black NIDDM subjects. , 1995, Kidney international.

[119]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[120]  B. Freedman,et al.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[121]  J. Miller,et al.  Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.

[122]  B. Freedman,et al.  Familial risk, age at onset, and cause of end-stage renal disease in white Americans. , 1995, Journal of the American Society of Nephrology : JASN.

[123]  R. Hanson,et al.  Diabetic nephropathy: a risk factor for diabetes mellitus in offspring , 1995, Diabetologia.

[124]  S. Greenhouse,et al.  Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group. , 1994, Kidney international.

[125]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[126]  R. Wolfe,et al.  Socioeconomic status and end-stage renal disease in the United States. , 1994, Kidney international.

[127]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.

[128]  L. Groop,et al.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria , 1994 .

[129]  L. Groop,et al.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. , 1994, JAMA.

[130]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[131]  J. Mathews,et al.  Renal disease patterns in Aboriginal Australians , 1993, The Medical journal of Australia.

[132]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[133]  P. Whelton,et al.  The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. , 1992, JAMA.

[134]  R. Neuwirth,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992, JAMA.

[135]  R. Wolfe,et al.  Patterns of low incidence of treated end-stage renal disease among the elderly. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[136]  S. Rosansky,et al.  Rate of change of end-stage renal disease treatment incidence 1978-1987--has there been selection? , 1992, Journal of the American Society of Nephrology : JASN.

[137]  K. Earle,et al.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.

[138]  M. Laville,et al.  Controlled low protein diets in chronic renal insufficiency: meta-analysis. , 1992, BMJ.

[139]  R. Wolfe,et al.  Geographic variation in the incidence of treated end-stage renal disease. , 1991, Journal of the American Society of Nephrology : JASN.

[140]  R. Kawamori,et al.  Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM. , 1991, Japanese journal of medicine.

[141]  P. Whelton,et al.  Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? , 1991, Archives of internal medicine.

[142]  N. Stowe,et al.  Lipoprotein abnormalities in the progression of renal disease. , 1990, Cleveland Clinic journal of medicine.

[143]  W. Hoy,et al.  Low incidence of glomerulosclerosis in normal kidneys. , 1989, Archives of pathology & laboratory medicine.

[144]  H. Parving,et al.  Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. , 1989, BMJ.

[145]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[146]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[147]  S. Klahr.  The modification of diet in renal disease study. , 1989, The New England journal of medicine.

[148]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.

[149]  C. Grim,et al.  A familial risk of chronic renal failure among blacks on dialysis? , 1988, Journal of clinical epidemiology.

[150]  B. Kasiske.  Relationship between vascular disease and age-associated changes in the human kidney. , 1987, Kidney international.

[151]  Z. Varghese,et al.  LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE , 1982, The Lancet.

[152]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[153]  B. Brenner,et al.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.

[154]  Baig Ar,et al.  Sex-chromatin values in rat epithelium. , 1967 .

[155]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[156]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[157]  Grace S. L. Lee,et al.  End-stage renal disease in the Asian-Pacific region. , 2003, Seminars in nephrology.

[158]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[159]  P. Bossuyt,et al.  Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[160]  P. Remington,et al.  Increasing incidence of end-stage renal disease in Wisconsin: an unintended consequence of increased survival? , 2001, WMJ : official publication of the State Medical Society of Wisconsin.

[161]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[162]  L. Diamond,et al.  Forum of the End-Stage Renal Disease Networks' role in implementing the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines. , 1999, Advances in renal replacement therapy.

[163]  R. D'Agostino,et al.  Clinical correlates of hypertensive end-stage renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[164]  J. Nedelman,et al.  Race, socioeconomic status, and the development of end-stage renal disease. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[165]  James W. Johnson,et al.  Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group. , 1993, The Journal of family practice.

[166]  E. Ferrari,et al.  Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. , 1989, International journal of obesity.

[167]  Surgeon General,et al.  Healthy people : the Surgeon General's report on health promotion and disease prevention , 1979 .